Old Web
English
Sign In
Acemap
>
authorDetail
>
Daniel Backenroth
Daniel Backenroth
Columbia University Medical Center
Population
Biology
Bendamustine
Performance status
AL amyloidosis
4
Papers
98
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Single cell RNA-Seq reveals pre-cDCs fate determined by transcription factor combinatorial dose
2019
Wenji Ma
Jaeyop Lee
Daniel Backenroth
Yu Jerry Zhou
Erin C. Bush
Peter A. Sims
Kang Liu
Yufeng Shen
Show All
Source
Cite
Save
Citations (11)
Updated Results of a Phase 2 Study of Bendamustine in Combination with Dexamethasone (Ben/Dex) in Patients with Previously-Treated Systemic Light-Chain (AL) Amyloidosis
2015
Blood
Suzanne Lentzsch
Raymond L. Comenzo
Jeffrey A. Zonder
Keren Osman
Miao Susanna
Daniel Backenroth
Daniel Otap
Wei-Yann Tsai
Siva Pregja
Shahzad Raza
Vaishali Sanchorawala
Heather Landau
Show All
Source
Cite
Save
Citations (3)
CANOES: detecting rare copy number variants from whole exome sequencing data
2014
Nucleic Acids Research
Daniel Backenroth
Jason Homsy
Laura R. Murillo
Joe Glessner
Edwin Lin
Martina Brueckner
Richard P. Lifton
Elizabeth Goldmuntz
Wendy K. Chung
Yufeng Shen
Show All
Source
Cite
Save
Citations (82)
Phase 2 Study of Bendamustine in Combination with Dexamethasone (Ben/Dex) in Patients with Previously-Treated Systemic Light Chain (AL) Amyloidosis
2014
Blood
Suzanne Lentzsch
Raymond L. Comenzo
Keren Osman
Kevin Zikaras
Daniel Backenroth
Wei-Yann Tsai
Vaishali Sanchorawala
Heather Landau
Show All
Source
Cite
Save
Citations (2)
1